{"article_title": "Guess Which Funds Missed the Gain, and Pain, of Valeant", "article_keywords": ["billion", "guess", "pain", "missed", "surprising", "tear", "funds", "valeant", "vanguard", "health", "gain", "stock", "valeants", "steep", "recent"], "article_url": "http://www.wsj.com/articles/guess-which-funds-missed-the-gain-and-pain-of-valeant-1449155431", "article_text": "The steep drop in Valeant Pharmaceuticals International Inc.\u2019s stock in recent months hurt a lot of investors, with a surprising exception: the two biggest mutual funds that specialize in health care.\n\nThe $51 billion Vanguard Health Care Fund and the $15 billion Fidelity Select Biotechnology Portfolio haven\u2019t invested in the drugmaker at least since 2011, even though Valeant\u2019s shares were on a tear before their recent dive.\n\n...", "article_metadata": {"article.template": "snippet", "article.created": "2015-12-03T15:10:00.000Z", "article.section": "Markets", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "The steep drop in Valeant\u2019s stock in recent months hurt a lot of investors, with a surprising exception: the two biggest mutual funds that specialize in health care.", "creator": "@bysarahkrouse", "image": {"src": "https://si.wsj.net/public/resources/images/BN-LN569_VALEAN_G_20151202163836.jpg", "alt": "Guess which funds missed the gain, and pain, of Valeant", "identifier": "https://si.wsj.net/public/resources/images/BN-LN569_VALEAN_D_20151202163836.jpg"}, "title": "Guess Which Funds Missed the Gain, and Pain, of Valeant", "site": "@WSJ", "card": "summary_large_image"}, "al": {"ios": {"url": "wsj://launch?articleid=SB10223228191091083831904581392052455560930&headline=Guess%20which%20funds%20missed%20the%20gain%2C%20and%20pain%2C%20of%20Valeant&weburl=http://www.wsj.com/articles/SB10223228191091083831904581392052455560930"}}, "page.site.product": "WSJ", "keywords": "drug companies,drugs,pharmaceuticals,valeant,valeant shares,Valeant Pharmaceuticals International,VRX.T,VRX,Fidelity Select Biotechnology Portfolio,Vanguard Health Care Fund,Allianz,ALV.XE,Fidelity Investments,Johnson & Johnson,JNJ,Pfizer,PFE,T. Rowe Price Group,TROW,Merck,MRK,Wellington Management,Allergan,AGN,Eventide Asset Management,Mylan%20N.V.,MYL,Colin Delaney,John Schroer,Laura Pavlenko,Michael Pearson,Rajiv Kaul,Hynes%2C%20Jean,political,general news,health,personal investments in mutual funds,personal finance,personal investments,trusts,funds,financial vehicles,unit trusts,mutual funds,health care,life sciences,financial services,generic drugs,investing,securities", "news_keywords": "drug companies,drugs,pharmaceuticals,valeant,valeant shares,Valeant Pharmaceuticals International,VRX.T,VRX,Fidelity Select Biotechnology Portfolio,Vanguard Health Care Fund", "article.headline": "Guess which funds missed the gain, and pain, of Valeant", "cXenseParse": {"candybar": {"image": "https://si.wsj.net/public/resources/images/BN-LN569_VALEAN_E_20151202163836.jpg"}, "poptart": {"image": "https://si.wsj.net/public/resources/images/BN-LN569_VALEAN_D_20151202163836.jpg"}}, "description": "The steep drop in Valeant\u2019s stock in recent months hurt a lot of investors, with a surprising exception: the two biggest mutual funds that specialize in health care.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB10223228191091083831904581392052455560930&headline=Guess%20which%20funds%20missed%20the%20gain%2C%20and%20pain%2C%20of%20Valeant&weburl=http://www.wsj.com/articles/SB10223228191091083831904581392052455560930", "user.type": "nonsubscriber", "article.page": "Markets", "article.emb": "video_emb", "page.content.format": "responsive", "article.summary": "The steep drop in Valeant\u2019s stock in recent months hurt a lot of investors, with a surprising exception: the two biggest mutual funds that specialize in health care.", "page.site": "wsj", "testkeys": "C", "article.published": "2015-12-03T20:13:00.000Z", "dj.asn": "i-4bd0", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"publisher": "https://www.facebook.com/wsj", "video_count": 1, "embed_count": 1, "word_count": 815, "internal_link_count": 7, "image_count": 2}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "The steep drop in Valeant\u2019s stock in recent months hurt a lot of investors, with a surprising exception: the two biggest mutual funds that specialize in health care.", "title": "Guess Which Funds Missed the Gain, and Pain, of Valeant", "url": "http://www.wsj.com/articles/guess-which-funds-missed-the-gain-and-pain-of-valeant-1449155431", "image": {"width": 553, "identifier": "https://si.wsj.net/public/resources/images/BN-LN569_VALEAN_G_20151202163836.jpg", "height": 369}, "locale": "en_US", "type": "article"}, "author": "Sarah Krouse", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "Guess Which Funds Missed the Gain, and Pain, of Valeant", "article.type": "Markets Main", "article.id": "SB10223228191091083831904581392052455560930", "user.exp": "default", "article.updated": "2015-12-03T20:13:00.000Z"}, "article_summary": "The steep drop in Valeant Pharmaceuticals International Inc.\u2019s stock in recent months hurt a lot of investors, with a surprising exception: the two biggest mutual funds that specialize in health care.\nThe $51 billion Vanguard Health Care Fund and the $15 billion Fidelity Select Biotechnology Portfolio haven\u2019t invested in the drugmaker at least since 2011, even though Valeant\u2019s shares were on a tear before their recent dive."}